HBIO Harvard Bioscience Inc
Price (delayed)
$0.388
Market cap
$17.1M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.28
Enterprise value
$56.33M
Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its customers range from renowned
Highlights
The EPS has grown by 15% from the previous quarter
The company's net income rose by 13% QoQ
Harvard Bioscience's debt has increased by 4.8% YoY but it has decreased by 2.8% from the previous quarter
HBIO's quick ratio has shrunk by 55% YoY and by 54% QoQ
The gross profit has declined by 17% year-on-year and by 4.1% since the previous quarter
Key stats
What are the main financial stats of HBIO
Market
Valuations
Earnings
Shares outstanding
44.07M
Market cap
$17.1M
Enterprise value
$56.33M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.27
Price to sales (P/S)
0.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.6
Revenue
$94.14M
Gross profit
$54.77M
Operating income
-$6.21M
Net income
-$12.41M
EBIT
-$8.46M
EBITDA
-$1.3M
Free cash flow
-$1.82M
Per share
Balance sheet
Liquidity
EPS
-$0.28
EPS diluted
-$0.28
Free cash flow per share
-$0.04
Book value per share
$1.45
Revenue per share
$2.16
TBVPS
$1.36
Total assets
$126.64M
Total liabilities
$63.3M
Debt
$43.34M
Equity
$63.34M
Working capital
-$9.84M
Debt to equity
0.68
Current ratio
0.82
Quick ratio
0.35
Net debt/EBITDA
-30.2
Margins
Efficiency
Dividend
EBITDA margin
-1.4%
Gross margin
58.2%
Net margin
-13.2%
Operating margin
-6.6%
Return on assets
-9.5%
Return on equity
-18.7%
Return on invested capital
-12.6%
Return on capital employed
-11.8%
Return on sales
-9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HBIO stock price
How has the Harvard Bioscience stock price performed over time
Intraday
-0.51%
1 week
0.6%
1 month
-44.18%
1 year
-90.51%
YTD
-81.61%
QTD
-31.45%
Financial performance
How have Harvard Bioscience's revenue and profit performed over time
Revenue
$94.14M
Gross profit
$54.77M
Operating income
-$6.21M
Net income
-$12.41M
Gross margin
58.2%
Net margin
-13.2%
The gross profit has declined by 17% year-on-year and by 4.1% since the previous quarter
Harvard Bioscience's revenue has decreased by 16% YoY and by 3.7% from the previous quarter
The company's net income rose by 13% QoQ
Harvard Bioscience's net margin has increased by 10% from the previous quarter
Growth
What is Harvard Bioscience's growth rate over time
Valuation
What is Harvard Bioscience stock price valuation
P/E
N/A
P/B
0.27
P/S
0.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.6
The EPS has grown by 15% from the previous quarter
HBIO's price to book (P/B) is 89% less than its 5-year quarterly average of 2.5 and 86% less than its last 4 quarters average of 1.9
The equity has declined by 13% year-on-year and by 3% since the previous quarter
The stock's price to sales (P/S) is 89% less than its 5-year quarterly average of 1.7 and 86% less than its last 4 quarters average of 1.3
Harvard Bioscience's revenue has decreased by 16% YoY and by 3.7% from the previous quarter
Efficiency
How efficient is Harvard Bioscience business performance
The ROS has grown by 13% from the previous quarter
The return on assets has increased by 11% since the previous quarter
The return on equity has grown by 10% since the previous quarter
HBIO's return on invested capital is up by 7% since the previous quarter
Dividends
What is HBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HBIO.
Financial health
How did Harvard Bioscience financials performed over time
The total assets is 100% more than the total liabilities
HBIO's current ratio has dropped by 60% since the previous quarter and by 56% year-on-year
HBIO's quick ratio has shrunk by 55% YoY and by 54% QoQ
Harvard Bioscience's debt is 32% less than its equity
The company's debt to equity rose by 19% YoY
The equity has declined by 13% year-on-year and by 3% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.